Bladder Cancer Clinical Trials in Tianjin
4 recruitingTianjin, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Bladder CancerImmunotherapyLiquid Biopsy
Tianjin Medical University Second Hospital53 enrolled1 locationNCT07475403
Recruiting
Not Applicable
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
Bladder CancerLiquid BiopsyCystoscopy
Tianjin Medical University Second Hospital360 enrolled2 locationsNCT07180212
Recruiting
The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer
Bladder CancerLiquid Biopsy
Tianjin Medical University Second Hospital60 enrolled2 locationsNCT07130578
Recruiting
Not Applicable
Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
Bladder CancerLiquid BiopsyRepeat Transurethral Resection of Bladder Tumor
Tianjin Medical University Second Hospital196 enrolled2 locationsNCT07187635